Alteration of blood-brain barrier integrity by retroviral infection

PLoS Pathogens

Volumn 4, Issue 11, 2008, Pages

  Afonso, Philippe V ^a   Ozden, Simona ^a   Cumont, Marie Christine ^a   Seilhean, Danielle ^b   Cartier, Luis ^c   Rezaie, Payam ^d   Mason, Sarah ^d   Lambert, Sophie ^e   Huerre, Michel ^a   Gessain, Antoine ^a   Couraud, Pierre Olivier ^e   Pique, Claudine ^e   Ceccaldi, Pierre Emmanuel ^a   Romero, Ignacio A ^a,d  

^a INSTITUT PASTEUR   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITY OF CHILE   (Chile)

^d OPEN UNIVERSITY   (United Kingdom)

^e INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPILIN 1; PROTEOHEPARAN SULFATE; VIRUS RECEPTOR;

ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; DEREGULATION; EMBRYO; ENDOTHELIUM CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MEMBRANE PERMEABILITY; NONHUMAN; PATHOGENESIS; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; VIRUS INFECTION; AUTOPSY; CELL LINE; PATHOLOGY; RETROVIRUS INFECTION; SPINAL CORD; TIGHT JUNCTION; VIROLOGY;

HUMAN T-LYMPHOTROPIC VIRUS 1;

AUTOPSY; BLOOD-BRAIN BARRIER; CELL LINE; ENDOTHELIAL CELLS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; PARAPARESIS, TROPICAL SPASTIC; RECEPTORS, VIRUS; RETROVIRIDAE INFECTIONS; SPINAL CORD; TIGHT JUNCTIONS;

EID: 57149118229     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000205     Document Type: Article

References (56)

1. Abbott NJ (2002) Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 200: 629-638.
2. Toborek M, Lee YW, Flora G, Pu H, Andras IE, et al. (2005) Mechanisms of the blood-brain barrier disruption in HIV-1 infection. Cell Mol Neurobiol 25: 181-199.
3. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, et al. (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2: 407-410.
4. Ozden S, Seilhean D, Gessain A, Hauw JJ, Gout O (2002) Severe demyelinating myelopathy with low human T cell lymphotropic virus type 1 expression after transfusion in an immunosuppressed patient. Clin Infect Dis 34: 855-860.
5. Akizuki S, Nakazato O, Higuchi Y, Tanabe K, Setoguchi M, et al. (1987) Necropsy findings in HTLV-I associated myelopathy. Lancet 1: 156-157.
6. Cavrois M, Gessain A, Gout O, Wain-Hobson S, Wattel E (2000) Common human T cell leukemia virus type 1 (HTLV-1) integration sites in cerebrospinal fluid and blood lymphocytes of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis indicate that HTLV-1 crosses the blood-brain barrier via clonal HTLV-1-infected cells. J Infect Dis 182: 1044-1050.
7. Osame M (2002) Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP). J Neurovirol 8: 359-364.
8. Afonso PV, Ozden S, Prevost MC, Schmitt C, Seilhean D, et al. (2007) Human blood-brain barrier disruption by retroviral-infected lymphocytes: role of myosin light chain kinase in endothelial tight-junction disorganization. J Immunol 179: 2576-2583.
9. Kim TG, Langridge WH (2004) Synthesis of an HIV-1 Tat transduction domain-rotavirus enterotoxin fusion protein in transgenic potato. Plant Cell Rep 22: 382-387.
10. Andras IE, Pu H, Deli MA, Nath A, Hennig B, et al. (2003) HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. J Neurosci Res 74: 255-265.
11. Masuda M, Hoffman PM, Ruscetti SK (1993) Viral determinants that control the neuropathogenicity of PVC-211 murine leukemia virus in vivo determine brain capillary endothelial cell tropism of the virus in vitro. J Virol 67: 4580-4587.
12. Rostad SW, Sumi SM, Shaw CM, Olson K, McDougall JK (1987) Human immunodeficiency virus (HIV) infection in brains with AIDS-related leukoencephalopathy. AIDS Res Hum Retroviruses 3: 363-373.
13. Ward JM, O'Leary TJ, Baskin GB, Benveniste R, Harris CA, et al. (1987) Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections. Am J Pathol 127: 199-205.
14. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A 83: 7089-7093.
15. Bissel SJ, Wiley CA (2004) Human immunodeficiency virus infection of the brain: pitfalls in evaluating infected/affected cell populations. Brain Pathol 14: 97-108.
16. Umehara F, Izumo S, Takeya M, Takahashi K, Sato E, et al. (1996) Expression of adhesion molecules and monocyte chemoattractant protein -1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy. Acta Neuropathol 91: 343-350.
17. Ho DD, Rota TR, Hirsch MS (1984) Infection of human endothelial cells by human T-lymphotropic virus type I. Proc Natl Acad Sci U S A 81: 7588-7590.
18. Hoxie JA, Matthews DM, Cines DB (1984) Infection of human endothelial cells by human T-cell leukemia virus type I. Proc Natl Acad Sci U S A 81: 7591-7595.
19. Setoyama M, Kerdel FA, Elgart G, Kanzaki T, Byrnes JJ (1998) Detection of HTLV-1 by polymerase chain reaction in situ hybridization in adult T-cell leukemia/lymphoma. Am J Pathol 152: 683-689.
20. Pinon JD, Klasse PJ, Jassal SR, Welson S, Weber J, et al. (2003) Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans. J Virol 77: 9922-9930.
21. Jones KS, Petrow-Sadowski C, Bertolette DC, Huang Y, Ruscetti FW (2005) Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells. J Virol 79: 12692-12702.
22. Ghez D, Lepelletier Y, Lambert S, Fourneau JM, Blot V, et al. (2006) Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry. J Virol 80: 6844-6854.
23. Manel N, Kim FJ, Kinet S, Taylor N, Sitbon M, et al. (2003) The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115: 449-459.
24. Parish CR (2006) The role of heparan sulphate in inflammation. Nat Rev Immunol 6: 633-643.
25. Floris S, van den Born J, van der Pol SM, Dijkstra CD, De Vries HE (2003) Heparan sulfate proteoglycans modulate monocyte migration across cerebral endothelium. J Neuropathol Exp Neurol 62: 780-790.
26. Szymocha R, Brisson C, Bernard A, Akaoka H, Belin MF, et al. (2000) Long-term effects of HTLV-1 on brain astrocytes: sustained expression of Tax-1 associated with synthesis of inflammatory mediators. J Neurovirol 6: 350-357.
27. Szymocha R, Akaoka H, Brisson C, Beurton-Marduel P, Chalon A, et al. (2000) Astrocytic alterations induced by HTLV type 1-infected T lymphocytes: a role for Tax-1 and tumor necrosis factor alpha. AIDS Res Hum Retroviruses 16: 1723-1729.
28. Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, et al. (2005) Blood-brain barrier-specific properties of a human adult brain endothelial cell line. Faseb J 19: 1872-1874.
29. Grant C, Barmak K, Alefantis T, Yao J, Jacobson S, et al. (2002) Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. J Cell Physiol 190: 133-159.
30. Romero IA, Prevost MC, Perret E, Adamson P, Greenwood J, et al. (2000) Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: mechanisms of viral entry into the central nervous system. J Virol 74: 6021-6030.
31. Fletcher NF, Brayden DJ, Brankin B, Callanan JJ (2008) Feline immunodeficiency virus infection: A valuable model to study HIV-1 associated encephalitis. Vet Immunol Immunopathol.
32. Takenouchi N, Jones KS, Lisinski I, Fugo K, Yao K, et al. (2007) GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1. J Virol 81: 1506-1510.
33. Mantych GJ, Sotelo-Avila C, Devaskar SU (1993) The blood-brain barrier glucose transporter is conserved in preterm and term newborn infants. J Clin Endocrinol Metab 77: 46-49.
34. Pardridge WM (1991) Advances in cell biology of blood-brain barrier transport. Semin Cell Biol 2: 419-426.
35. Broholm H, Laursen H (2004) Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors. Apmis 112: 257-263.
36. Zhang ZG, Tsang W, Zhang L, Powers C, Chopp M (2001) Up-regulation of neuropilin-1 in neovasculature after focal cerebral ischemia in the adult rat. J Cereb Blood Flow Metab 21: 541-549.
37. Bangham CR, Osame M (2005) Cellular immune response to HTLV-1. Oncogene 24: 6035-6046.
38. Wielgosz MM, Rauch DA, Jones KS, Ruscetti FW, Ratner L (2005) Cholesterol dependence of HTLV-I infection. AIDS Res Hum Retroviruses 21: 43-50.
39. Delamarre L, Rosenberg AR, Pique C, Pham D, Dokhelar MC (1997) A novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity. J Virol 71: 259-266.
40. Ceccaldi PE, Delebecque F, Prevost MC, Moris A, Abastado JP, et al. (2006) DC-SIGN facilitates fusion of dendritic cells with human T-cell leukemia virus type 1-infected cells. J Virol 80: 4771-4780.
41. Giraudon P, Buart S, Bernard A, Thomasset N, Belin MF (1996) Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-I). Prog Neurobiol 49: 169-184.
42. Takashima H, Eguchi K, Kawakami A, Kawabe Y, Migita K, et al. (1996) Cytokine production by endothelial cells infected with human T cell lymphotropic virus type I. Ann Rheum Dis 55: 632-637.
43. Banerjee P, Rochford R, Antel J, Canute G, Wrzesinski S, et al. (2007) Proinflammatory cytokine gene induction by human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 Tax in primary human glial cells. J Virol 81: 1690-1700.
44. Mori N, Prager D (1997) Transactivation of the interleukin-1 alpha promoter by human T-cell leukemia virus. Leuk Lymphoma 26: 421-433.
45. McKenzie JA, Ridley AJ (2007) Roles of Rho/ROCK and MLCK in TNF-alpha-induced changes in endothelial morphology and permeability. J Cell Physiol 213: 221-228.
46. Sierralta J, Mendoza C (2004) PDZ-containing proteins: alternative splicing as a source of functional diversity. Brain Res Brain Res Rev 47: 105-115.
47. Rousset R, Fabre S, Desbois C, Bantignies F, Jalinot P (1998) The C-terminus of the HTLV-1 Tax oncoprotein mediates interaction with the PDZ domain of cellular proteins. Oncogene 16: 643-654.
48. Kehn K, Fuente Cde L, Strouss K, Berro R, Jiang H, et al. (2005) The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation. Oncogene 24: 525-540.
49. Bazarbachi A, Abou Merhi R, Gessain A, Talhouk R, El-Khoury H, et al. (2004) Human T-cell lymphotropic virus type I-infected cells extravasate through the endothelial barrier by a local angiogenesis-like mechanism. Cancer Res 64: 2039-2046.
50. El-Sabban ME, Merhi RA, Haidar HA, Arnulf B, Khoury H, et al. (2002) Human T-cell lymphotropic virus type 1-transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells. Blood 99: 3383-3389.
51. Royer-Leveau C, Mordelet E, Delebecque F, Gessain A, Charneau P, et al. (2002) Efficient transfer of HTLV-1 tax gene in various primary and immortalized cells using a flap lentiviral vector. J Virol Methods 105: 133-140.
52. Cartier LM, Cea JG, Vergara C, Araya F, Born P (1997) Clinical and neuropathological study of six patients with spastic paraparesis associated with HTLV-I: an axomyelinic degeneration of the central nervous system. J Neuropathol Exp Neurol 56: 403-413.
53. Seilhean D, Duyckaerts C, Vazeux R, Bolgert F, Brunet P, et al. (1993) HIV-1-associated cognitive/motor complex: absence of neuronal loss in the cerebral neocortex. Neurology 43: 1492-1499.
54. Tangy F, Vernant JC, Coscoy L, Ossondo M, Bellance R, et al. (1995) A search for human T-cell leukemia virus type I in the lesions of patients with tropical spastic paraparesis and polymyositis. Ann Neurol 38: 454-460.
55. Chevalier SA, Walic M, Calattini S, Mallet A, Prevost MC, et al. (2007) Construction and characterization of a full-length infectious simian T-cell lymphotropic virus type 3 molecular clone. J Virol 81: 6276-6285.
56. Dehouck MP, Jolliet-Riant P, Bree F, Fruchart JC, Cecchelli R, et al. (1992) Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models. J Neurochem 58: 1790-1797.